News und Analysen
Dalata Hotel Group PLC: TVR-Total Voting Rights
Dalata Hotel Group PLC: HOL-Holding(s) in Company*
Humana’s 2026 Medicare Advantage Plans Prioritize Simplicity, Stability and Quality Care for Beneficiaries
Humana Inc. (NYSE: HUM), a leading health and well-being company, today announced its Medicare Advantage and Medicare Prescription Drug Plan offerings for 2026. During the Medicare Annual Election
FICO Survey Shows South Africans Will Bend the Truth to Access Credit
FICO (NYSE: FICO):
Global analytics software leader FICO has announced its findings from the 2025 FICO Consumer Survey: Fraud, Identity and Digital Banking South Africa, which show a rising
Turkiye Garanti Bankasi A.S.: Announcement regarding JCR Credit Rating
Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Morgan Stanley Statement on Stress Capital Buffer Reconsideration
The Federal Reserve announced today that it has reduced Morgan Stanley’s Stress Capital Buffer (SCB) from 5.1% to 4.3%, effective on October 1, 2025 in response to the Firm seeking reconsideration
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Novo Nordisk A/S (“Novo” or the “Company”) (NYSE: NVO) and reminds investors of the September
Bayer Selects Interpublic as Global Media, Production and Creative Agency Partner for Consumer Health Division
The Consumer Health division of Bayer has selected Interpublic Group (NYSE: IPG) as the global agency partner for all creative, production and media, responsible for marketing activities for some
Dalata Hotel Group PLC: Holding(s) in Company
Bayer to Highlight New Data for KERENDIA® (finerenone) at Heart Failure Society of America (HFSA) Annual Scientific Meeting 2025
Bayer announced today that data from across the KERENDIA® (finerenone) comprehensive clinical trial program will be presented at the Heart Failure Society of America (HFSA)’s Annual Scientific
Dalata Hotel Group PLC: HOL-Holding(s) in Company*
CarMax Reports Second Quarter Fiscal Year 2026 Results
CarMax, Inc. (NYSE:KMX) today reported results for the second quarter ended August 31, 2025.
Second Quarter Highlights:(1)
-
Retail used unit sales decreased 5.4% and comparable store used
Notification of managers’ transactions
Schindler and Accor enter a service agreement in Asia
Dalata Hotel Group PLC: HOL-Holding(s) in Company*
Intuit Rapidly Advances GenOS to Accelerate Development of Agentic AI Experiences at Scale
Intuit Inc. (Nasdaq: INTU), the global financial technology platform that makes Intuit TurboTax, Credit Karma, QuickBooks, and Mailchimp, has rapidly advanced its proprietary Generative AI
Partners Group will be strategic partner and portfolio manager of Deutsche Bank's first evergreen private markets fund
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Fiserv
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Fiserv, Inc. (“Fiserv” or the “Company”) (NYSE: FI) and reminds investors of the September
Form 8.3 - The Vanguard Group, Inc.: Dalata Hotel Group plc
Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Notification of manager’s transaction
Nebius Group announces exercise of the underwriters' option to purchase additional Class A shares
Bayer First Company to Advance Cell Therapy as Well as Gene Therapy Against Parkinson’s Disease
Bayer announced today progress for two potential therapies against Parkinson’s disease (PD). A first participant received randomized treatment in the pivotal Phase III clinical trial, exPDite-2, of
FICO Survey: Only 1 in 10 APAC Bank Leaders Say Their Bank Is Highly Advanced in Hyper-Personalization
(NYSE: FICO)
Highlights
-
Only 11% of executives say their bank is highly advanced in hyper-personalization -
72% admit their customer communication channels are siloed or only partly



